- Risk of graft loss on once-daily versus twice-daily tacrolimus in kidney transplant patients: a meta-analysis
-
Kandarini Y, Mahadita GW, Widiana IGR, Paramita Ayu N
- KMID: 2535444
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S227.
- doi: 10.4285/ATW2022.F-3635
Background: Tacrolimus has been used as immunosuppressant for various organ transplantation, including kidney. Recently, clinician is more interested in using once-daily tacrolimus compared to twice-daily due to higher adherence. One... -
- CITED
-
- Close
- SHARE
-
- Close
